INTRODUCTION
The National Service Framework (NSF) for Coronary Heart Disease (CHD) 1 published in 2000 defines national standards for the application of appropriate secondary prevention measures to those at risk of cardiovascular disease, including those with peripheral arterial disease (PAD). Symptoms of coronary artery disease or electrocardiographic abnormality are found in half of patients presenting with PAD, and coronary angiography abnormalities and duplex evidence of carotid artery disease have been found in 90% and 40% respectively. 2 Furthermore, PAD has been found to be an independent predictor of increased risk of cardiovascular death. In patients with symptomatic PAD there is a 30% risk of death within 5 years and nearly 50% within 10 years, primarily due to myocardial infarction (MI) (60%) or stroke (12%). 2 An aggressive approach is therefore required to modify risk factors to reduce the risk of fatal and non-fatal MI and stroke in patients with PAD. 2 Currently the management of patients with established CHD is substandard, 3, 4 and even when recommendations are implemented there is much variation in the care that patients receive. 5 Secondary prevention strategies in patients with PAD are likely to be worse than for patients with CHD. For example, a recent study focusing on cholesterol management in general practice showed that patients with stroke or PAD achieved poorer cholesterol control than those with CHD. In this study approximately 50% of patients with PAD and 43% with a stroke had cholesterol levels <5mmol/l compared to 60% of patients with CHD. 6 The objectives of this survey were:
• To assess current standards of secondary prevention measures and health monitoring in patients with PAD following a vascular procedure.
• To compare standards of secondary prevention in patients with PAD with and without diagnosed CHD.
METHODS

Design
The survey was designed as a retrospective record review of GP held medical records (paper and electronic). Evidence based indicators for the study were identified from national recommendations and evidence, 1, 2, [7] [8] [9] [10] [11] [12] (Table 1) . A structured data collection form was designed to collect data for each indicator and relevant supplementary information.
The six primary care trusts (PCTs) in Leicestershire were approached and asked if they were willing to participate in the multi-practice survey. Three PCTs agreed to participate and a letter of invitation was then sent to all 87 general practices identified in the 3 PCTs at that time. Practices who failed to respond were sent a second letter. If no reply was received after the second letter a follow up telephone call was made to the practices. This cross sectional survey was carried out as part of a local quality assurance programme between primary and secondary care. As such it constituted the first stage of a planned audit conducted to identify and compare levels of care, therefore, statistical significance was not sought in our analysis of the data collected. Additionally, the survey did not require ethics committee approval. 
RESULTS
Number of practices taking part and patient records reviewed
Three of the 6 PCTs agreed to participate and of the 87 practices in these 3 PCTs, 53 had eligible patients (see Figure 1 ). Of these, 42 (79%) agreed to take part in the survey. In total, 137 eligible patients were identified and data were collected for 103 (75%). The median number of patient records reviewed per practice was 2 (range 1 to 7).
Practice characteristics
A higher proportion of practices who participated were teaching practices and group practices compared to those who declined to take part, (see Table 2 ). Teaching practices represented 18% of eligible practices who did not agree, compared to 43% of practices where data were collected. Group practices represented 64% of eligible practices who did not agree, compared to 83% of practices where data were collected. 
Patient characteristics
Characteristics of patients in our sample are shown in Table 3 . A higher proportion of patients whose records were reviewed was male (62%) than female (38%). The mean age for all patients was 73 years (standard deviation (SD) 11.0), however, females were on average older than males (mean age 77 years (SD 11.0) for females, and 70 years (SD 10.0) for males). The mean number of months since the procedure was carried out for PAD was 29 (SD 3.6). Overall 69% of patients had a history of hypertension, and 50% of patients had cardiovascular disease (diagnosed with one or more of stroke, angina, or MI). In addition, although only 26% of patients were current smokers, 79% of patients had a history of smoking ever (current smoker or ex-smoker). Table 1 shows current standards of practice for our survey sample.
Current standards of practice
Secondary prevention -prescribing:
Prescription rates of medication for secondary prevention measures were well achieved for aspirin or clopidogrel (88%) but much lower for statins (68% for all patients, and 53%
currently for patients with cholesterol >5mmol/l).
Health monitoring and prevention in the preceding 12 months:
Annual blood pressure monitoring (87%), smoking status check (83%), and cessation advice to current smokers (96%) were all well achieved. The proportion of patients who had a cholesterol check was less well achieved (71%) and the percentages of patients who had their BMI checked (50%) or whose records indicated that they had received exercise (walking) advice (56%) were even lower.
Intermediate outcomes of care:
Cholesterol level <5mmol/l was achieved for 75% of patients but blood pressure <140/85mmHg was achieved for only 48%. However, 85% of patients with a blood pressure >140/85 mmHg were currently prescribed antihypertensive medication.
Standards of secondary prevention in patients with PAD and diagnosed
CHD compared to PAD patients with no diagnosed CHD
Standards of care for patients who had undergone a recent procedure for PAD and additionally had a diagnosis of CHD, were better than for patients who had PAD without diagnosed CHD, for all indicators (see Table 1 ). Blood pressure control showed only a very marginal difference (49% in patients with CHD and 47% in patients with no CHD). However, statin prescribing, exercise advice and assessment of BMI showed very noticeable differences between patients with PAD with and without diagnosed CHD (statin if total cholesterol >5mmol/l 100% vs. 36%, exercise advice 77% vs. 41%, BMI check 73% vs. 40%).
DISCUSSION
Summary of main findings
This cross sectional survey suggests that standards of secondary prevention measures in patients with symptomatic PAD recently discharged from secondary care following a vascular procedure are suboptimal. Additionally, in our sample, standards of secondary prevention in patients with PAD without a diagnosis of CHD were much poorer than for patients with both diagnoses. This is in spite of PAD being an independent risk factor for fatal and non fatal MI.
Strengths and limitations
It is acknowledged that our results may not be a true reflection of secondary prevention in all practices as only 53 (61%) of the 87 practices in the 3 participating PCTs were eligible to take part in the survey. However, the other 34 practices did not have any patients who were discharged following a vascular procedure for PAD in 2003, and overall we collected data for 75% of eligible patients. There were some differences in the characteristics of eligible practices who did not agree to the survey compared to those that participated, in terms of teaching status and the proportion of practices that were single handed (Table 2) . However, these differences are unlikely to have had a substantial impact as the differences were not statistically significant.
The small number of patient records reviewed at some practices may limit the representativeness of the findings. As patient records were reviewed approximately 2 years following admission there was some loss of cases due to deaths or patients having left the practice where they were registered at the time of their vascular procedure.
Comparison with other studies
Our sample was small compared to a recent audit of cholesterol management in cardiovascular disease in English general practices, 6 which included a subset of 3,617 patients with PAD. In the latter study 50% of patients with PAD had a cholesterol level <5mmol/l compared to 75% of patients in our survey. However, our survey considered only PAD patients who had undergone a recent vascular procedure and were therefore of higher risk, whereas the cholesterol management audit collected data on all patients with a diagnosis of PAD. A study conducted in secondary care in the USA 13 which looked at a similar group of patients to our survey, also found that patients received sub-optimal treatment following discharge after undergoing a vascular procedure. respectively for the QoF CHD data. However, our survey considered care in the previous 12 months whereas QoF data looks at a 15 month period. Although the proportions achieving total cholesterol levels <5 mmol/l were very similar (75% in this study vs. 79% for QoF data), BP targets were very poorly achieved (48% for patients with PAD vs. 87% QoF).
However, BP targets in our study were lower than the QoF targets (<140/85 and <150/90 respectively). Standards of care for patients with PAD who additionally had a diagnosis of CHD were similar to the QoF CHD data, with the exception of blood pressure control.
The recently published Scottish Intercollegiate Guidelines Network (SIGN) guidelines on the Diagnosis and management of peripheral arterial disease 15 include guidance on secondary prevention of cardiovascular events. Indicators that were utilized in this survey are similar to the SIGN recommendations (smoking cessation, cholesterol lowering, BP control, antiplatelet therapy). However, tighter control of cholesterol is recommended by SIGN, < 3.5 mmol/l compared to < 5.0 mmol/l in this survey.
CONCLUSION
In spite of national and international recommendations and strong evidence of an increased risk of death due to cardiovascular disease, currently the treatment received by some patients with established PAD is substandard. There is considerable potential to increase secondary prevention of CHD in patients with PAD, using appropriate evidence based management.
More attention needs to be given to this group of patients in primary care in order to improve secondary prevention.
